These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8043091)

  • 1. Hormone replacement therapy.
    MacMahon S; North D
    N Z Med J; 1994 May; 107(977):185. PubMed ID: 8043091
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and breast cancer.
    Kemp JF; Baber RJ
    Med J Aust; 1993 May; 158(10):722. PubMed ID: 8338542
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone replacement therapy and breast cancer].
    Mueck AO
    Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormone therapy and breast cancer].
    Olsen J
    Ugeskr Laeger; 2003 Sep; 165(38):3631-2. PubMed ID: 14556398
    [No Abstract]   [Full Text] [Related]  

  • 5. [Postmenopausal hormone replacement therapy--is there a cause of worry?].
    Skouby SO; Wilken-Jensen C; Jespersen J; Pedersen AT; Ottesen BS
    Ugeskr Laeger; 2002 Aug; 164(34):3974-5. PubMed ID: 12212482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postmenopausal hormone replacement under scrutiny. "Fatal therapy"?].
    Braendle W; Semler J
    MMW Fortschr Med; 2000 Aug; 142(33-34):11-2. PubMed ID: 10998894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone replacement therapy in patients after breast cancer].
    Köninger A; Kümmel S; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormone replacement therapy in menopause].
    Breckwoldt M
    Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
    [No Abstract]   [Full Text] [Related]  

  • 9. Menopausal hormone replacement therapy and risk of breast cancer. Implications for the treatment of osteoporosis in postmenopausal women.
    Lopes P
    Rev Rhum Engl Ed; 1996 May; 63(5):309-11. PubMed ID: 8789875
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of post-menopausal hormone replacement.
    Snyder RD
    Aust N Z J Med; 1992 Oct; 22(5):507; author reply 508-9. PubMed ID: 1294148
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
    Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
    J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].
    Lopes P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684
    [No Abstract]   [Full Text] [Related]  

  • 13. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy.
    Reid IR
    N Z Med J; 1994 Apr; 107(975):138. PubMed ID: 8145969
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen replacement therapy and breast cancer.
    Maguire PJ
    J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 20. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R
    J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.